首页> 外文期刊>Journal of population therapeutics and clinical pharmacology >Use of Continuous Exposure Variables When Examining Dose-Dependent Pharmacological Effects Application to the Association Between Exposure to Higher Statin Doses and the Incidence of Diabetes
【24h】

Use of Continuous Exposure Variables When Examining Dose-Dependent Pharmacological Effects Application to the Association Between Exposure to Higher Statin Doses and the Incidence of Diabetes

机译:在检查剂量依赖性药理作用应用于较高他汀类药物剂量与糖尿病发生率之间的关联时,使用连续暴露变量

获取原文
           

摘要

Background: Many observational studies have found an association between the exposure to statins and the increased risk of diabetes, mostly through the use of intent-to-treat (ITT) like exposure measure (EM). ITT like EM may not adequately reflect the mechanism of action by which statins could cause diabetes.Objective: To determine if continuous EMs can more accurately reflect the mechanism of action by which statins and incidence of diabetes would be associated than ITT like EM.Methods: We obtained a cohort of 404,129 diabetes-free incident statin users from the Quebec public drug insurance plan. Patients dispensed with a drug used in the treatment of diabetes or diagnosed with diabetes within 2-years follow-up were defined as cases. Controls were randomly matched to each case on the index date. Three EMs were tested, EM 1: exposure to a high versus low dose statin at baseline (ITT like); EM 2: cumulative standardized statin dose (cSSD) at the index date; and EM 3: cSSD in the 180 days prior to the index date. The optimal EM was selected based upon each model’s Akaike’s information criterion (AIC). Conditional logistic regressions were used to calculate conditional OR and model AIC.Results: All three EMs identified an increased risk of diabetes among patients exposed to higher statin doses. Model AIC identified EM 3 as the best EM for this association.Conclusion: Our results indicate that higher statin doses increase the risk of diabetes but favour a cumulative reversible diabetogenic effect of statins.
机译:背景:许多观察性研究发现,他汀类药物的暴露与糖尿病风险的增加之间存在关联,主要是通过使用意向性治疗(ITT)之类的暴露量度(EM)。目的:确定连续的EM是否比EM这样的ITT更能准确地反映出他汀类药物与糖尿病发生率相关的作用机理,从而确定像EM这样的EM可能无法充分反映他汀类药物可能导致糖尿病的作用机理。我们从魁北克公共药品保险计划中获得了404,129名无糖尿病他汀类药物使用者。将分配有用于治疗糖尿病或在2年随访中被诊断出患有糖尿病的药物的患者定义为病例。对照在索引日期与每个病例随机匹配。测试了三个EM,EM 1:在基线时暴露于高剂量他汀类药物或低剂量他汀类药物(ITT类); EM 2:在索引日期累积的标准他汀类药物剂量(cSSD); EM 3:索引日期前180天内的cSSD。根据每个模型的Akaike的信息标准(AIC)选择了最佳EM。结果:所有三个EM均发现暴露于他汀类药物剂量较高的患者中,糖尿病风险增加。模型AIC将EM 3确定为与此相关的最佳EM。结论:我们的结果表明,他汀类药物剂量越高,患糖尿病的风险越大,但他汀类药物具有累积的可逆性致糖尿病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号